Interdisciplinary exchange of ideas: progestagens for autoimmunity, biologics for pregnancy complications

详细信息    查看全文

• 作者：Abraham Tsur (1)
  Grant C. Hughes (2)
  Yehuda Shoenfeld (3) (4)
  Howard Carp (1) (4)
  
  1. Obstetrics and Gynecology ; Chaim Sheba Medical Center ; Tel Hashomer ; Ramat Gan ; Israel
  2. Division of Rheumatology ; Department of Medicine ; University of Washington ; Seattle ; WA ; USA
  3. Zabludowicz Center for Autoimmune Diseases ; Chaim Sheba Medical Center ; Tel Hashomer ; Ramat Gan ; Israel
  4. Sackler School of Medicine ; Tel Aviv University ; Tel Aviv ; Israel
  
• 关键词：Progesterone ; Immunomodulation ; Preterm labor ; Recurrent pregnancy loss ; Biologics ; T cells
• 刊名：Immunologic Research
• 出版年：2015
• 出版时间：February 2015
• 年：2015
• 卷：61
• 期：1-2
• 页码：31-34
• 全文大小：228 KB
• 参考文献：1. Combs CA, Gravett M, Garite TJ, Hickok DE, Lapidus J, Porreco R, et al. Amniotic fluid infection, inflammation, and colonization in preterm labor with intact membranes. Am J Obstet Gynecol. 2014;210(2):125.e1鈥?5. doi:10.1016/j.ajog.2013.11.032 . CrossRef
  2. Kim SM, Romero R, Lee J, Mi Lee S, Park CW, Shin Park J, et al. The frequency and clinical significance of intra-amniotic inflammation in women with preterm uterine contractility but without cervical change: Do the diagnostic criteria for preterm labor need to be changed? J Matern Fetal Neonatal Med. 2012;25(8):1212鈥?1. doi:10.3109/14767058.2011.629256 . CrossRef
  3. Moura E, Mattar R, de Souza E, Torloni MR, Gon莽alves-Primo A, Daher S. Inflammatory cytokine gene polymorphisms and spontaneous preterm birth. J Reprod Immunol. 2009;80(1鈥?):115鈥?1. doi:10.1016/j.jri.2008.11.007 . CrossRef
  4. Wei SQ, Fraser W, Luo ZC. Inflammatory cytokines and spontaneous preterm birth in asymptomatic women: a systematic review. Obstet Gynecol. 2010;116(2 Pt 1):393鈥?01. doi:10.1097/AOG.0b013e3181e6dbc0 . CrossRef
  5. Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost. 2006;4(2):295鈥?06. doi:10.1111/j.1538-7836.2006.01753.x . CrossRef
  6. Csapo AI, Pulkkinen M. Indispensability of the human corpus luteum in the maintenance of early pregnancy luteectomy evidence. Obstet Gynecol Surv. 1978;33(2):69鈥?1. CrossRef
  7. Peyron R, Aub茅ny E, Targosz V, Silvestre L, Renault M, Elkik F, et al. Early termination of pregnancy with mifepristone (RU 486) and the orally active prostaglandin misoprostol. N Engl J Med. 1993;328(21):1509鈥?3. doi:10.1056/NEJM199305273282101 . CrossRef
  8. Cunningham FG, Leveno KJ, Bloom SL, Spong CY, S. DJ, Hoffman BL et al. Placentation, embryogenesis, and fetal development. In: Cunningham FG, Leveno KJ, Bloom SL, Spong CY, S. DJ, Hoffman BL et al., editors. Willimas obstetrics. 24th ed. New York: McGraw-Hill Education/Medical; 2014. p. 106鈥?5.
  9. Committee on Practice Bulletins鈥擮bstetrics. TeACoOaG. Practice bulletin no. 130: prediction and prevention of preterm birth. Obstet Gynecol. 2012;120(4):964鈥?3. doi:10.1097/AOG.0b013e3182723b1b . CrossRef
  10. Romero R, Nicolaides K, Conde-Agudelo A, Tabor A, O鈥橞rien JM, Cetingoz E, et al. Vaginal progesterone in women with an asymptomatic sonographic short cervix in the midtrimester decreases preterm delivery and neonatal morbidity: a systematic review and metaanalysis of individual patient data. Am J Obstet Gynecol. 2012;206(2):124.e1鈥?9. doi:10.1016/j.ajog.2011.12.003 . CrossRef
  11. Norwitz ER, Robinson JN, Challis JR. The control of labor. N Engl J Med. 1999;341(9):660鈥?. doi:10.1056/NEJM199908263410906 . CrossRef
  12. Challis JRG, Matthews SG, Gibb W, Lye SJ. Endocrine and paracrine regulation of birth at term and preterm. Endocr Rev. 2000;21(5):514鈥?0. doi:10.1210/edrv.21.5.0407 .
  13. Okabe H, Makino S, Kato K, Matsuoka K, Seki H, Takeda S. The effect of progesterone on genes involved in preterm labor. J Reprod Immunol. 2014;. doi:10.1016/j.jri.2014.03.008 .
  14. Haas DM, Ramsey PS. Progestogen for preventing miscarriage. Cochrane Database Syst Rev. 2013;10:CD003511. doi:10.1002/14651858.CD003511.pub3 .
  15. Kwak-Kim J, Bao S, Lee SK, Kim JW, Gilman-Sachs A. Immunological modes of pregnancy loss: inflammation, immune effectors, and stress. Am J Reprod Immunol. 2014;. doi:10.1111/aji.12234 .
  16. Choi BC, Polgar K, Xiao L, Hill JA. Progesterone inhibits in vitro embryotoxic Th1 cytokine production to trophoblast in women with recurrent pregnancy loss. Hum Reprod. 2000;15(Suppl. 1):46鈥?9. CrossRef
  17. Hughes GC. Progesterone and autoimmune disease. Autoimmun Rev. 2012;11(6鈥?):A502鈥?4. doi:10.1016/j.autrev.2011.12.003 . CrossRef
  18. Arck PC, Hecher K. Fetomaternal immune cross-talk and its consequences for maternal and offspring鈥檚 health. Nat Med. 2013;19(5):548鈥?6. doi:10.1038/nm.3160 . CrossRef
  19. Kaushic C, Roth KL, Anipindi V, Xiu F. Increased prevalence of sexually transmitted viral infections in women: the role of female sex hormones in regulating susceptibility and immune responses. J Reprod Immunol. 2011;88(2):204鈥?. doi:10.1016/j.jri.2010.12.004 . CrossRef
  20. Kourtis AP, Read JS, Jamieson DJ. Pregnancy and infection. N Engl J Med. 2014;370(23):2211鈥?. doi:10.1056/NEJMra1213566 . CrossRef
  21. Rowe JH, Ertelt JM, Aguilera MN, Farrar MA, Way SS. Foxp3(+) regulatory T cell expansion required for sustaining pregnancy compromises host defense against prenatal bacterial pathogens. Cell Host Microbe. 2011;10(1):54鈥?4. doi:10.1016/j.chom.2011.06.005 . CrossRef
  22. Sakiani S, Olsen NJ, Kovacs WJ. Gonadal steroids and humoral immunity. Nat Rev Endocrinol. 2013;9(1):56鈥?2. doi:10.1038/nrendo.2012.206 . CrossRef
  23. Arnold JN, Wormald MR, Sim RB, Rudd PM, Dwek RA. The impact of glycosylation on the biological function and structure of human immunoglobulins. Annu Rev Immunol. 2007;25:21鈥?0. doi:10.1146/annurev.immunol.25.022106.141702 . CrossRef
  24. Prados MB, La Blunda J, Szekeres-Bartho J, Caramelo J, Miranda S. Progesterone induces a switch in oligosaccharyltransferase isoform expression: consequences on IgG N-glycosylation. Immunol Lett. 2011;137(1鈥?):28鈥?7. doi:10.1016/j.imlet.2011.01.017 . CrossRef
  25. Hughes GC, Clark EA. Regulation of dendritic cells by female sex steroids: relevance to immunity and autoimmunity. Autoimmunity. 2007;40:470鈥?1. CrossRef
  26. Ostensen M, Villiger PM. The remission of rheumatoid arthritis during pregnancy. Semin Immunopathol. 2007;29(2):185鈥?1. doi:10.1007/s00281-007-0072-5 . CrossRef
  27. Vukusic S, Ionescu I, El-Etr M, Schumacher M, Baulieu EE, Cornu C, et al. The Prevention of Post-Partum Relapses with Progestin and Estradiol in Multiple Sclerosis (POPART鈥橫US) trial: rationale, objectives and state of advancement. J Neurol Sci. 2009;286(1鈥?):114鈥?. doi:10.1016/j.jns.2009.08.056 . CrossRef
  28. Weinblatt ME, Kremer JM, Bankhurst AD, Bulpitt KJ, Fleischmann RM, Fox RI, et al. A trial of etanercept, a recombinant tumor necrosis factor receptor: Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate. N Engl J Med. 1999;340(4):253鈥?. doi:10.1056/NEJM199901283400401 . CrossRef
  29. Smolen JS, Beaulieu A, Rubbert-Roth A, Ramos-Remus C, Rovensky J, Alecock E, et al. Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial. Lancet. 2008;371(9617):987鈥?7. doi:10.1016/S0140-6736(08)60453-5 . CrossRef
  30. Jones G, Sebba A, Gu J, Lowenstein MB, Calvo A, Gomez-Reino JJ, et al. Comparison of tocilizumab monotherapy versus methotrexate monotherapy in patients with moderate to severe rheumatoid arthritis: the AMBITION study. Ann Rheum Dis. 2010;69(1):88鈥?6. doi:10.1136/ard.2008.105197 . CrossRef
  31. Singh JA, Beg S, Lopez-Olivo MA. Tocilizumab for rheumatoid arthritis: a Cochrane systematic review. J Rheumatol. 2011;38(1):10鈥?0. doi:10.3899/jrheum.100717 . CrossRef
  32. Ostensen M. Safety issues of biologics in pregnant patients with rheumatic diseases. Ann N Y Acad Sci. 2014;1317(1):32鈥?. doi:10.1111/nyas.12456 . CrossRef
  33. Porter TF, LaCoursiere Y, Scott JR. Immunotherapy for recurrent miscarriage. Cochrane Database Syst Rev. 2006;2:CD000112. doi:10.1002/14651858.CD000112.pub2 .
  34. Carp HJ, Toder V, Torchinsky A, Portuguese S, Lipitz S, Gazit E, et al. Allogenic leukocyte immunization after five or more miscarriages. Recurrent Miscarriage Immunotherapy Trialists Group. Hum Reprod. 1997;12(2):250鈥?. CrossRef
  35. Daya S, Gunby J. The effectiveness of allogeneic leukocyte immunization in unexplained primary recurrent spontaneous abortion. Recurrent Miscarriage Immunotherapy Trialists Group. Am J Reprod Immunol. 1994;32(4):294鈥?02. CrossRef
  36. Hutton B, Sharma R, Fergusson D, Tinmouth A, Hebert P, Jamieson J, et al. Use of intravenous immunoglobulin for treatment of recurrent miscarriage: a systematic review. BJOG. 2007;114(2):134鈥?2. doi:10.1111/j.1471-0528.2006.01201.x . CrossRef
  37. Jerzak M, Ohams M, G贸rski A, Baranowski W. Etanercept immunotherapy in women with a history of recurrent reproductive failure. Ginekol Pol. 2012;83(4):260鈥?.
  38. Scarpellini F, Sbracia M. Use of granulocyte colony-stimulating factor for the treatment of unexplained recurrent miscarriage: a randomised controlled trial. Hum Reprod. 2009;24(11):2703鈥?. doi:10.1093/humrep/dep240 . CrossRef
  39. Siiteri PK, Febres F, Clemens LE, Chang RJ, Gondos B, Stites D. Progesterone and maintenance of pregnancy: Is progesterone nature鈥檚 immunosuppressant? Ann N Y Acad Sci. 1977;286:384鈥?7. CrossRef
  
• 刊物主题：Allergology; Immunology; Medicine/Public Health, general; Internal Medicine;
• 出版者：Springer US
• ISSN：1559-0755

文摘

In recent years, there has been a growing interest in the role of immune, alloimmune and autoimmune processes in the pathogenesis of spontaneous preterm birth and recurrent pregnancy loss. The association between an inflammatory response and preterm labor has been established. Indeed, many women suffering from preterm labor have elevated inflammatory markers such as tumor necrosis factor alpha, interleukin 6 and matrix metaloproeinase 8. The role of immune processes in the pathogenesis of recurrent pregnancy loss has also been widely researched. Progesterone induces many physiologic effects necessary for healthy pregnancy, and progestagens supplementation has been used as an approach to prevent preterm labor and recurrent pregnancy loss. Progestagens also have potent anti-inflammatory and immunomodulatory actions. Because preterm labor and recurrent pregnancy loss are associated with abnormal inflammation, progestagens may maintain healthy pregnancy through both endocrine and immunologic actions. These immunologic actions, such as suppression of Th1- and Th17-related responses, enhancement of regulatory T cell (Tregs) activity and suppression of inflammation, may also be involved in pregnancy-induced remission of certain autoimmune diseases such as rheumatoid arthritis (RA) and multiple sclerosis (MS). Accordingly, there is growing interest in the potential therapeutic role of progestagens in the treatment of MS and RA. In this review, we suggest that biologic autoimmune modulators, especially those which affect immune pathways similar to progestagens, may provide more potent and specific effects, and hence better results than progestagens, in preventing preterm labor and recurrent pregnancy loss.